Nimodipine in pharma franchise in Maharashtra

Nimodipine in PCD pharma franchise in Chandigarh

Nimodipine in top pharma company in Kolkata

Nimodipine in pcd pharma supplier in Vadodara

Nimodipine in phama franchise company in india
Nimodipine in phama distributor in Nagpur

Home/Products /nimodipine-10mg-injection

Nimoplit Injection

Composition : Nimodipine (10mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 10mg/50ml

Price : ₹790/-

Nimoplit Injection contains Nimodipine (10mg), a calcium channel blocker primarily used to prevent and treat cerebral vasospasm following subarachnoid hemorrhage (SAH). By relaxing and widening blood vessels in the brain, it enhances cerebral blood flow and reduces the risk of secondary brain damage due to reduced oxygen supply.

Nimodipine is highly effective in neurology and is often used in critical care settings to improve neurological recovery after a brain hemorrhage. It also exhibits potential benefits in preventing stroke-related complications and protecting brain cells from ischemic damage.

Administered intravenously, Polyflip B Injection is recommended for short-term use in intensive care settings, where close monitoring of blood pressure and heart function is essential. It plays a crucial role in improving patient outcomes by ensuring adequate oxygenation of brain tissues.

Read More

About the Product

Nimoplit Injection contains Nimodipine (10mg), a calcium channel blocker primarily used to prevent and treat cerebral vasospasm following subarachnoid hemorrhage (SAH). By relaxing and widening blood vessels in the brain, it enhances cerebral blood flow and reduces the risk of secondary brain damage due to reduced oxygen supply.

Nimodipine is highly effective in neurology and is often used in critical care settings to improve neurological recovery after a brain hemorrhage. It also exhibits potential benefits in preventing stroke-related complications and protecting brain cells from ischemic damage.

Administered intravenously, Polyflip B Injection is recommended for short-term use in intensive care settings, where close monitoring of blood pressure and heart function is essential. It plays a crucial role in improving patient outcomes by ensuring adequate oxygenation of brain tissues.

May cause low blood pressure, dizziness, headache, nausea, flushing, and slow heart rate.

Used for the prevention and treatment of cerebral vasospasm in patients with subarachnoid hemorrhage (SAH).

Administer under strict medical supervision, with continuous monitoring of blood pressure and heart function.

Store at 15°C to 30°C, away from light. Do not refrigerate or freeze.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation